I. Dans-les-chondrocytes-primaires-arthrosiques and .. , 83 A-Modèle de surexpression de Nox4 et p22phox par rétrovirus, p.83

V. De-nox4-sur-modèle-in-vivo and .. , 91 I- VDAC est présent à la membrane des érythrocytes, p.92

I. De-la-surexpression-de-vdac-dans-les-Érythrocytes and .. , 96 A-Augmentation de l'activité réductase par fusion de protéoliposomes, p.96

F. Morel, Molecular aspects of chronic granulomatous disease.the NADPH oxidase complex, Bulletin de l'Academie nationale de medecine, pp.377-390, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00400465

K. Morita, Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification, The Journal of Experimental Medicine, vol.6, issue.7, pp.1613-1636, 2007.
DOI : 10.1016/j.bbrc.2005.10.166

URL : http://jem.rupress.org/content/jem/204/7/1613.full.pdf

. Nauseef, Assembly of the phagocyte NADPH oxidase, Histochemistry and Cell Biology, vol.90, issue.4, pp.277-91, 2004.
DOI : 10.1007/s00418-004-0679-8

M. Nguyen, Recombinant Nox4 cytosolic domain produced by a cell or cellfree base systems exhibits constitutive diaphorase activity, pp.453-458, 2012.
DOI : 10.1016/j.bbrc.2012.01.136

URL : https://hal.archives-ouvertes.fr/hal-00821156

M. Nguyen, B. Lardy, and F. Rousset, Quinone compounds regulate the level of ROS production by the NADPH oxidase Nox4, Biochemical Pharmacology, vol.85, issue.11, pp.1644-1654, 2013.
DOI : 10.1016/j.bcp.2013.03.023

M. Paclet, Localization of Nox2 N-terminus using polyclonal antipeptide antibodies, Biochemical Journal, vol.382, issue.3, pp.981-986, 2004.
DOI : 10.1042/BJ20040954

URL : https://hal.archives-ouvertes.fr/hal-00820738

A. Poole, Cartilage in health and disease, pp.226-284, 2001.

. Poole, Cellular biology of cartilage degradation. Mechanisms and models in rheumatoid arthritis London, pp.163-204, 1997.